Skip to main content

Advertisement

Table 1 Clinicopathological characteristics of 502 patients with upper tract urothelial carcinoma

From: The diagnostic ureteroscopy before radical nephroureterectomy in upper urinary tract urothelial carcinoma is not associated with higher intravesical recurrence

  All patients (n=502) URS or not
  Yes (n=206) No (n=296) p value
No. (%) No. (%) No. (%)  
Age(years)(mean [SD]) 65.8 (11.0) 66.1 (10.1) 65.7 (11.6) 0.705
Gender     0.334
 Male (%) 220 (43.8) 85 (41.3) 135 (45.6)  
 Female (%) 282 (56.2) 121 (58.7) 161 (54.4)  
Smoking     0.984
 Yes (%) 105 (20.9) 43 (20.9) 62 (20.9)  
 No (%) 397 (79.1) 163 (79.1) 234 (79.1)  
Bladder cancer history     0.958
 Yes (%) 148 (29.5) 61 (29.6) 87 (29.4)  
 No (%) 354 (70.5) 145 (70.4) 209 (70.6)  
eGFR (mL/min/1.73 m2) (median [range]) 49.4 (2.9-154.3)    0.544
60 (%) 175 (34.9) 75 (36.4) 100 (33.8)  
 <60 (%) 327 (65.1) 131 (63.6) 196 (66.2)  
Dialysis     0.476
 Yes (%) 76 (15.1) 34 (16.5) 42 (14.2)  
 No (%) 426 (84.9) 172 (83.5) 254 (85.8)  
Surgical modality     *< 0.001
 Open (%) 329 (65.5) 110 (53.4) 219 (74.0)  
 Laparoscopy (%) 155 (30.9) 90 (43.7) 65 (22.0)  
 Segmental resection (%) 18 (3.6) 6 (2.9) 12 (4.1)  
Tumor location     0.711
 Pelvis (%) 190 (37.8) 76 (36.9) 114 (38.5)  
 Ureter (%) 221 (44.0) 95 (46.1) 126 (42.6)  
 Both (%) 91 (18.1) 35(17.0) 56 (18.9)  
Multifocality     0.389
 Yes (%) 117 (23.3) 44 (21.4) 73 (24.7)  
 No (%) 385 (76.7) 162 (78.6) 223 (75.3)  
Tumor grade     0.592
 Low (%) 111 (22.1) 48 (23.2) 63 (21.3)  
 High (%) 391 (77.9) 158 (76.7) 233 (78.7)  
Pathologic T stage     0.319
 pTa-Tis (%) 71 (14.1) 36 (17.5) 35 (11.8)  
 pT1 (%) 131 (26.1) 54 (26.2) 77 (26.0)  
 pT2 (%) 127 (25.3) 47 (22.8) 80 (27.0)  
 pT3 (%) 144 (28.7) 55 (26.7) 89 (30.1)  
 pT4 (%) 29 (5.8) 14 (6.8) 15 (5.1)  
Pathologic N     0.999
 N0 or Nx (%) 463 (92.2) 190 (92.2) 273 (92.2)  
 N1-3 (%) 39 (7.8) 16 (7.8) 23 (7.8)  
  1. *p<0.05